Who founded Concertobio?

Concertobio was founded by Jared Kehe, Cheri Ackerman, Bernardo Cervantes in 2020.

Who are Concertobio's investors?

Concertobio's investors include Excelestar Ventures, Golden Seeds, Horizons Ventures, ISV, M Ventures, MassVentures, Axial VC.

How much funding has Concertobio raised?

Concertobio has disclosed $24.5M raised across 1 round.

Where is Concertobio headquartered?

Concertobio is headquartered in Cambridge, US.

Concertobio

Cambridge, US · Founded 2020 · Delaware corporation · 7 known investors

Concerto Bio generates large-scale ecological datasets on microbial communities and uses them to develop microbe-based consumer health products for applications such as skincare, chronic disease, and nutrition. Its approach combines high-throughput experimental data generation with predictive modeling to make microbial communities engineerable.

AI & Machine Learning Biotech Deep Tech

Founders & leadership

Concertobio was founded in 2020 by Jared Kehe, Cheri Ackerman, and Bernardo Cervantes.

Jared KeheCo-founder

Cheri AckermanCo-founder

Bernardo CervantesinCo-founder

Vera SchroederNamed on SEC filing

Board

Sarah Luppino inBoard DirectorAssociate at M Ventures

Investors · 7

Excelestar VenturesAndover

Golden SeedsFlushing · $250K – $2M

Horizons VenturesHong Kong · $1M – $110M

ISVWest Palm Beach

M VenturesLos Angeles · $10.8M

MassVenturesWaltham · $250K – $500K

Axial VCreportedSan Francisco · $100K – $5M

Reported raises · per SEC filings

Form D private placements

$24.5M disclosed across 1 round · 2022

▶$24.5MraisedJun 2022 · 37 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Sarah LuppinoDirector
Vera SchroederDirector
Jared KeheExecutive Officer, Director
Cheri AckermanExecutive Officer, Director
Bernardo CervantesExecutive Officer, Director

Offering amount: $24.5M
Amount sold: $24.5M
First sale: Mar 2022
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

bio15 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.

Actio Biosciences, Inc.14 shared keywordsActio is a precision medicine company that translates genetic insights into new therapeutics, developing drugs that target the genes underlying both rare diseases and more prevalent conditions. It focuses on identifying dysregulated gene activity and designing therapies to restore balance and address the root causes of disease.

Scioto Biosciences12 shared keywordsScioto Biosciences is a life sciences company with corporate offices and research facilities in Fishers, Indiana. This page describes its office locations and employee benefits rather than detailing its products.

Ditto Biosciences12 shared keywordsDitto Bio uses AI to identify protein candidates from parasites and pathogens for treating autoimmune diseases. The company mines natural compounds from viruses, ticks, and worms whose immune-modulating properties have evolved over millions of years.

Companies competing with Concertobio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Concertobio do?: Concerto Bio generates large-scale ecological datasets on microbial communities and uses them to develop microbe-based consumer health products for applications such as skincare, chronic disease, and nutrition. Its approach combines high-throughput experimental data generation with predictive modeling to make microbial communities engineerable.
Who founded Concertobio?: Concertobio was founded by Jared Kehe, Cheri Ackerman, Bernardo Cervantes in 2020.
Who are Concertobio's investors?: Concertobio's investors include Excelestar Ventures, Golden Seeds, Horizons Ventures, ISV, M Ventures, MassVentures, Axial VC.
How much funding has Concertobio raised?: Concertobio has disclosed $24.5M raised across 1 round.
Where is Concertobio headquartered?: Concertobio is headquartered in Cambridge, US.